TST or IGRA in healthcare workers: The when and the why

Healthcare personnel are at increased risk of tuberculosis (TB) infection. In this webinar, Dr. Wendy Thanassi, professor and Director of Workforce Health at Stanford Medical Center and Hospital, will give an overview of screening healthcare professionals for TB infection. She will discuss the risks of TB infection and latent TB reactivation in the occupational health setting, and describe current testing guidelines. She will also explain the operational and medical differences between the Mantoux/tuberculin skin test (TST) and modern TB blood tests (interferon-gamma release assay tests – IGRAs).

Key learning objectives

Learn about the operational differences between the TST and IGRAsUnderstand the medical differences between the TST and IGRAsUnderstand the current policy recommendations for TST and IGRA use in healthcare workers

Who should attend?

Healthcare workers, clinicians, physicians, nurses, employee health directors, infectious disease specialists, and lab directors.

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Speakers

Georgina Wynne Hughes
Georgina Wynne Hughes
Editorial Assistant, SelectScience
Wendy Thanassi MA, MD, MRO
Wendy Thanassi MA, MD, MRO
Professor, Internal Medicine and Population Health; Director, Workforce Health and Wellness, Stanford Medical Center and Hospital</p>

Links

Tags